Transgene-Free Disease-Specific Induced Pluripotent Stem Cells from Patients with Type 1 and Type 2 Diabetes

The induced pluripotent stem cell (iPSC) technology enables derivation of patient-specific pluripotent stem cells from adult somatic cells without using an embryonic cell source. Redifferentiation of iPSCs from diabetic patients into pancreatic islets will allow patient-specific disease modeling and...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kudva, Yogish C., Ohmine, Seiga, Greder, Lucas V., Dutton, James R., Armstrong, Adam, De Lamo, Josep Genebriera, Khan, Yulia Krotova, Thatava, Tayaramma, Hasegawa, Mamoru, Fusaki, Noemi, Slack, Jonathan M.W., Ikeda, Yasuhiro
Médium: Artigo
Jazyk:Inglês
Vydáno: AlphaMed Press 2012
Témata:
Embryonic Stem Cells/Induced Pluripotent Stem (iPS) Cells
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3652675/
https://ncbi.nlm.nih.gov/pubmed/23197849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2011-0044
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky